NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
10 hedge funds and large institutions have $351K invested in NeuroMetrix, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
43% more funds holding
Funds holding: 7 → 10 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
51% less capital invested
Capital invested by funds: $714K → $351K (-$363K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$35.9K |
| 2 |
Goldman Sachs
New York
|
+$29.9K |
| 3 |
Morgan Stanley
New York
|
+$17.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15.7K |
| 5 |
Barclays
London,
United Kingdom
|
+$1.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$62K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$31K |
| 3 |
WAS
WESPAC Advisors SoCal
Pasadena,
California
|
-$753 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $123K | -$62K | -83 | -24% |
|
|
BIT
2
BlackRock Institutional Trust
San Francisco,
California
| $95K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $69K | +$35.9K | +48 | +49% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $21K | – | – | – |
|
|
5
Goldman Sachs
New York
| $19K | +$29.9K | +40 | New |
|
|
6
Morgan Stanley
New York
| $11K | +$17.2K | +23 | New |
|
|
TSS
7
Two Sigma Securities
New York
| $10K | +$15.7K | +21 | New |
|
|
BFA
8
BlackRock Fund Advisors
San Francisco,
California
| $1K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $1K | +$747 | +1 | New |
|
|
10
Barclays
London,
United Kingdom
| $1K | +$1.49K | +2 | New |
|
|
VKH
11
Virtu KCG Holdings
New York
| – | -$31K | -31 | Closed |
|
|
WAS
12
WESPAC Advisors SoCal
Pasadena,
California
| – | -$753 | -1 | Closed |
|
NURO Hedge Fund Activity: Q4 2016 in Review
10 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2016, worth a combined $351K — down 51% from $714K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NURO positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $35.9K. The largest seller was Sabby Management, cutting an estimated $62K.
- 10 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2016, up from 7 in Q3 2016.
- Funds reported $351K of NeuroMetrix, Inc. Common Stock stock for Q4 2016, down 51% quarter-over-quarter.
- 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2016 and 2 closed out, a net change of +3 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2016 was Renaissance Technologies, an estimated $35.9K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q4 2016 was Sabby Management, an estimated $62K sold.
Based on aggregated 13F filings for Q4 2016.